NASDAQ:RNXT
RenovoRx, Inc.
- Stock
Last Close
1.42
17/05 20:00
Market Cap
11.23M
Beta: -
Volume Today
29.06K
Avg: 55.01K
PE Ratio
−1.91
PFCF: −1.75
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 350K - | 343.50K 1.86% | 529.50K 54.15% | 547.50K 3.40% | ||
average receivables | ||||||
book value per share | -1.30 - | -1.75 34.14% | 2.94 268.31% | 0.68 76.86% | -0.29 142.82% | |
capex per share | -0.00 - | |||||
capex to depreciation | -1.67 - | |||||
capex to operating cash flow | 0.00 - | |||||
capex to revenue | ||||||
cash per share | 0.25 - | 0.21 14.69% | 2.91 1,260.19% | 0.94 67.79% | 0.11 87.85% | |
days of inventory on hand | ||||||
days payables outstanding | ||||||
days sales outstanding | ||||||
debt to assets | 1.46 - | |||||
debt to equity | -0.19 - | |||||
dividend yield | ||||||
earnings yield | -0.06 - | -0.07 16.13% | -0.28 290.11% | -0.46 63.45% | -0.43 5.48% | |
enterprise value | 58.77M - | 61.87M 5.27% | 10.06M 83.74% | 14.83M 47.46% | 22.39M 50.98% | |
enterprise value over ebitda | -15.34 - | -19.28 25.72% | -1.76 90.89% | -1.49 15.17% | -1.96 31.82% | |
ev to operating cash flow | -17.54 - | -17.54 0.04% | -1.70 90.30% | -1.68 0.99% | -2.18 29.68% | |
ev to sales | ||||||
free cash flow per share | -0.40 - | -0.42 5.31% | -1.14 170.18% | -0.97 14.38% | -1.00 2.41% | |
free cash flow yield | -0.06 - | -0.06 5.31% | -0.23 305.27% | -0.41 76.35% | -0.44 5.09% | |
graham net net | -1.32 - | -1.76 33.20% | 2.73 255.05% | 0.82 70.13% | -0.32 139.21% | |
graham number | 3.63 - | 4.54 24.81% | 9.49 109.22% | 4.07 57.14% | 2.55 37.20% | |
income quality | 0.87 - | 0.93 6.45% | 0.94 0.71% | 0.89 4.76% | 1.00 12.52% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -5.43 - | 6.80 225.21% | -174.56 2,667.17% | -105.52 39.55% | ||
interest debt per share | 0.40 - | -0.16 139.66% | 0.01 103.94% | 0.01 66.66% | ||
inventory turnover | ||||||
invested capital | -0.19 - | |||||
market cap | 60.87M - | 60.87M 0% | 25.25M 58.52% | 21.27M 15.76% | 23.57M 10.78% | |
net current asset value | -10.93M - | -14.66M 34.13% | 15.34M 204.66% | 6.16M 59.83% | -3.29M 153.43% | |
net debt to ebitda | 0.55 - | -0.31 156.47% | 2.65 955.71% | 0.65 75.61% | 0.10 84.10% | |
net income per share | -0.45 - | -0.52 16.13% | -1.36 160.07% | -1.08 20.64% | -0.99 7.89% | |
operating cash flow per share | -0.40 - | -0.42 5.31% | -1.13 169.49% | -0.97 14.16% | -1.00 2.41% | |
payables turnover | ||||||
receivables turnover | ||||||
research and ddevelopement to revenue | ||||||
return on tangible assets | -1.66 - | -2.29 37.73% | -0.44 80.98% | -1.34 208.70% | -6.98 418.95% | |
revenue per share | ||||||
roe | 0.35 - | 0.30 13.43% | -0.46 254.52% | -1.59 242.94% | 3.41 315.13% | |
roic | 0.35 - | 0.31 11.11% | -0.41 232.98% | -1.60 284.78% | 3.80 338.13% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | -1.30 - | -1.75 34.14% | 2.94 268.31% | 0.68 76.86% | -0.29 142.82% | |
stock based compensation to revenue | ||||||
tangible asset value | -10.93M - | -14.66M 34.14% | 15.35M 204.73% | 6.16M 59.85% | -3M 148.68% | |
tangible book value per share | -1.30 - | -1.75 34.14% | 2.94 268.31% | 0.68 76.86% | -0.29 142.82% | |
working capital | 1.46M - | -2.19M 249.62% | 15.34M 801.88% | 6.16M 59.83% | -2K 100.03% |
All numbers in USD (except ratios and percentages)